Literature DB >> 1527549

Gliomyosarcoma: an immunohistochemical analysis.

S R Stapleton1, W Harkness, P R Wilkins, D Uttley.   

Abstract

Tumours of mixed glial and sarcomatous elements occurring in intracranial neoplasms are well recognised and have been termed gliosarcomas. These tumours account for up to 8% of all glioblastomas. The sarcomatous elements are thought to derive from the neoplastic transformation of mesenchymal cells in or adjacent to the tumour. This transformation usually has the appearance of a fibrosarcoma or angiosarcoma. Alternative mesenchymal neoplastic differentiation may occur, however, giving rise to the appearances of chondrosarcoma and osteosarcoma. In 1969 Goldman described a case in which the sarcomatous elements of a mixed gliosarcoma appeared, on the basis of light microscopy alone, to differentiate towards skeletal muscle having the features of a rhabdomyosarcoma. He coined the term gliomyosarcoma. In 1986 Barnard et al reported a second case and demonstrated the features of rhabdomyosarcoma using the electron microscope. A further case characterised with both light microscopic and immunohistochemical techniques is reported.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527549      PMCID: PMC489217          DOI: 10.1136/jnnp.55.8.728

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  16 in total

1.  Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors).

Authors:  J M Woodruff; N L Chernik; M C Smith; W B Millett; F W Foote
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

2.  Gliomyosarcoma. Report of a case of rhabdomyosarcoma arising in a malignant glioma.

Authors:  R O Barnard; R Bradford; T Scott; D G Thomas
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  Neoplasms of mixed mesenchymal and neuroepithelial origin. Relation to "monstrocellular sarcoma" or "giant-celled glioblastoma".

Authors:  S Shuangshoti; M G Netsky
Journal:  J Neuropathol Exp Neurol       Date:  1971-04       Impact factor: 3.685

4.  Clinical and pathological study of 24 cases of gliosarcoma.

Authors:  R A Morantz; I Feigin; J Ransohoff
Journal:  J Neurosurg       Date:  1976-10       Impact factor: 5.115

5.  Cerebral mixed tumour: osteo-condrosarcoma--glioblastoma multiforme.

Authors:  J Sarmiento; I Ferrer; L Pons; E Ferrer
Journal:  Acta Neurochir (Wien)       Date:  1979       Impact factor: 2.216

6.  Primary rhabdomyosarcoma of the cerebrum.

Authors:  F Gyorkey; B Halpert
Journal:  Cancer       Date:  1975-05       Impact factor: 6.860

7.  Medullomyoblastoma. A teratoma.

Authors:  C Chowdhury; S Roy; A K Mahapatra; R Bhatia
Journal:  Cancer       Date:  1985-04-01       Impact factor: 6.860

Review 8.  Subependymoma with rhabdomyosarcomatous differentiation: report of a case and literature review.

Authors:  F H Tomlinson; B W Scheithauer; P J Kelly; G S Forbes
Journal:  Neurosurgery       Date:  1991-05       Impact factor: 4.654

Review 9.  Malignant ectomesenchymoma of soft tissue. Report of two cases and review of the literature.

Authors:  E H Kawamoto; N Weidner; R M Agostini; R Jaffe
Journal:  Cancer       Date:  1987-05-15       Impact factor: 6.860

10.  Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.

Authors:  M Altmannsberger; K Weber; R Droste; M Osborn
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.